GlassScriptPhysician profile
Eugene Rubach
NPI 1881692200
$90,058.59
in general payments reported to CMS, 2019-2025
29 companies · $7,073 in 2025
The $7,073 reported for 2025 was more than what 93% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,543 · 2020: $35K · 2021: $1,837 · 2022: $35K · 2023: $2,379 · 2024: $3,308 · 2025: $7,073.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,511 · Food and Beverage: $5,754 · Travel and Lodging: $494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,511.00 |
| Food and Beverage | $5,754.36 |
| Travel and Lodging | $494.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $38,029.44 | 2019-2020 | |
| Medtronic, INC. | $35,747.07 | 2021-2025 | Abre, Maxtack, Rapidvac |
| Tela Bio, INC. | $6,732.08 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Medical Device Business Services, INC. | $1,983.68 | 2019-2024 | Echelon Flex |
| Ethicon INC. | $1,482.80 | 2023-2025 | Megadyne, Mega Soft |
| Ethicon US, LLC | $888.17 | 2019-2025 | Echelon Endopath, Ethicon, Vistaseal |
| Stryker Corporation | $504.95 | 2022-2023 | 1688 |
| Kestra Medical Technology Services, INC. | $489.30 | 2022-2025 | Assure Wcd |
| Abbott Laboratories | $462.35 | 2019-2020 | |
| Boston Scientific Corporation | $392.37 | 2021-2025 | Spyglass Discover |
| Applied Medical Resources Corporation | $375.00 | 2023 | |
| Intuitive Surgical, INC. | $305.75 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $271.81 | 2024-2025 | |
| Integra Lifesciences Corporation | $271.36 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Merck Sharp & Dohme LLC | $244.54 | 2019-2025 | Bridion, Verquvo |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $238.81 | 2024 | Airseal, Visiclear |
| Olympus America INC. | $207.74 | 2019-2025 | Endoeye Flex Deflectable Videoscope |
| Biotronik INC. | $168.54 | 2020-2021 | |
| Medtronic Vascular, INC. | $165.13 | 2019 | |
| Enterra Medical, INC. | $152.06 | 2024 | |
| Ethicon Endo-Surgery INC. | $150.00 | 2022 | |
| Guard Medical INC. | $143.24 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $138.13 | 2019-2025 | Caldolor |
| Activ Surgical, INC. | $137.00 | 2022 | |
| Baxter Healthcare | $122.43 | 2021 | |
| W. L. Gore & Associates, INC. | $101.24 | 2019 | |
| Davol INC. | $100.00 | 2021 | |
| Chiesi USA, INC. | $38.81 | 2021-2024 | Cleviprex, Kengreal |
| Galvanize Therapeutics, INC | $14.79 | 2023 | Aliya System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Rubach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.